Clinical Trials

NCT04036695 | COMPLETED | NA
18 participants

Arrhythmia in Hemodialysis Patients

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-26
Start Date:
2019-10-17
Completion:
2023-05-01
Conditions
  • Arrythmia, Cardiac
  • Sudden Cardiac Death
  • Hemodialysis
Interventions
  • DEVICE
No Results Yet
NCT03961568 | COMPLETED | PHASE3
147 participants

Cenobamate Open-Label Extension Study for YKP3089C025

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-26
Start Date:
2019-08-13
Completion:
2026-06-10
Conditions
  • Primary Generalized Tonic Clonic Seizures in the Setting of Idiopathic Generalized Epilepsy
Interventions
  • DRUG
No Results Yet
NCT03761875 | ACTIVE_NOT_RECRUITING | NA
80 participants

NK Cell Deregulation in HBV Patients

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-26
Start Date:
2018-12-11
Completion:
2026-11-11
Conditions
  • Hepatitis B Virus
Interventions
  • OTHER
No Results Yet
NCT03507270 | COMPLETED | NA
20 participants

One-hour Diagnostic Algorithm for NSTEMI

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-26
Start Date:
2017-05-02
Completion:
2018-05-01
Conditions
  • Non ST Segment Elevation Myocardial Infarction
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT02795052 | RECRUITING | NA
500 participants

Neurologic Stem Cell Treatment Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-26
Start Date:
2016-06-30
Completion:
2027-07-31
Conditions
  • Neurologic Disorders
  • Nervous System Diseases
  • Neurodegenerative Diseases
  • Neurological Disorders
  • Stroke
  • Traumatic Brain Injury
  • Cadasil
  • Chronic Traumatic Encephalopathy
  • Cerebral Infarction
  • Cerebral Ischemia
  • Cerebral Stroke
  • Cerebral Hemorrhage
  • Parkinson
  • Multi-System Degeneration
  • MSA - Multiple System Atrophy
  • Progressive Supranuclear Palsy
  • ALS
  • Amyotrophic Lateral Sclerosis
  • Neuropathy
  • Diabetic Neuropathies
  • Alzheimer Disease
  • Dementia
  • Frontotemporal Dementia
  • Lewy Body Disease
  • Cognitive Impairment
  • Lewy Body Variant of Alzheimer Disease
Interventions
  • PROCEDURE
No Results Yet
NCT02520791 | ACTIVE_NOT_RECRUITING | PHASE1
21 participants

Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-26
Start Date:
2016-09-13
Completion:
2024-12-18
Conditions
  • Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
  • Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type
  • Recurrent Grade 1 Follicular Lymphoma
  • Recurrent Grade 2 Follicular Lymphoma
  • Recurrent Grade 3a Follicular Lymphoma
  • Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
  • Recurrent Mycosis Fungoides
  • Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
  • Refractory Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type
  • Refractory Grade 1 Follicular Lymphoma
  • Refractory Grade 2 Follicular Lymphoma
  • Refractory Grade 3a Follicular Lymphoma
  • Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
  • Stage IB Mycosis Fungoides AJCC v7
  • Stage II Mycosis Fungoides AJCC v7
  • Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma
  • Stage III Mycosis Fungoides AJCC v7
  • Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma
  • Stage IV Mycosis Fungoides AJCC v7
Interventions
  • BIOLOGICAL
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page